Certara’s Steve Sibley, Vice President Regulatory Strategy, is quoted in this Pharma’s Almanac article about the challenges of balancing faster drug approvals with patient safety and efficacy. Read the article to get Steve’s thoughts on how eCTD submissions, automation, and structured content management can help streamline workflows, minimize redundancies, and ensure consistency across global filings.
Date: March 26, 2025
Learn more about Regulatory Services and Medical Communications
Certara’s regulatory science services empower you to write a better submission, navigate global regulations, and achieve timely approvals. From early stage strategy to post marketing compliance, we ensure your pathway to market is efficient and compliant in any phase.
Sign up to newsletter
Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.
